He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
In this article Michael J. Bloch, MD, writes about the potential use of a polypill for cardiovascular disease prevention and discusses how the results of recent research supports the potential use in the...
